Medtronic completes $585M acquisition of CathWorks

robot
Abstract generation in progress

Medtronic has finalized its $585 million acquisition of CathWorks, a medical device company specializing in coronary artery disease diagnosis and treatment. This acquisition, which includes potential earn-out payments, follows a 2022 strategic partnership and aims to enhance Medtronic’s cardiology portfolio with CathWorks’ AI-powered FFRangio System. The system offers a non-invasive method for assessing coronary arteries, proven non-inferior to traditional methods in a recent clinical trial.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin